Healthy Skepticism Library item: 3050

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Young RS.
Who reviews the ads?
N Engl J Med 1980 Jan 31; 302:(5):295-6

Abstract:

Although the Food and Drug Administration has the statutory responsibility to review therapeutic claims and prescribing information its failure to fulfil the latter task allows inappropriate and misleading statements to appear in ads touting “a line of antitumor drugs.” Doctors who are troubled by inappropriate and misleading drug claims should complain directly to Congressional subcommittees.

Keywords:
*letter to the editor/United States/journal advertisements/regulation of promotion/Food and Drug Administration/FDA/Congressional subcommittee/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION Advertising* Antineoplastic Agents/standards* Humans Legislation, Drug United States United States Food and Drug Administration